Evidence map›Paper›PMID 32640193›Full record

ArticleMolecular cell2020

Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation.

Sang Bae Lee, Aram Ko, Young Taek Oh, Peiguo Shi, Fulvio D'Angelo, Brulinda Frangaj, Antonius Koller, Emily I Chen, Timothy Cardozo, Antonio Iavarone and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sang Bae LeeInstitute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA.
Aram KoInstitute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA.
Young Taek OhInstitute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA.
Peiguo ShiInstitute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA.
Fulvio D'AngeloInstitute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA.
Brulinda FrangajInstitute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA.
Antonius KollerProteomics Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA.
Emily I ChenProteomics Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA.
Timothy CardozoDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, NYU Langone Health, New York, NY 10016, USA.
Antonio IavaroneInstitute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA; Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA. Electronic address: ai2102@columbia.edu.
Anna LasorellaInstitute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA. Electronic address: al2179@columbia.edu.
Columbia University Irving Medical Center · USNYU Langone Health · US

Funding

Topology of Cancer Evolution and HeterogeneityU54CA193313 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO, RABADAN, RAUL · 2015 to 2020
$10.4M
The role of Id proteins in tumor development and angiogenesis in the brainR01CA101644 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LASORELLA, ANNA · 2003 to 2013
$3.5M
Computational analysis of Human High Grade GliomasR01NS061776 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO · 2009 to 2013
$2.4M
Identification and modeling of driver genetic modules in glioblastomaR01CA179044 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO, RABADAN, RAUL · 2014 to 2018
$2.3M
The role of the LZTR1 ubiquitin ligase in stem cells and cancerR01CA190891 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO · 2015 to 2019
$1.9M
The mechanisms driving brain oncogenesis by FGFR-TACC gene fusionsR01CA178546 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO · 2014 to 2018
$1.8M
Mechanisms of ID2 regulation in gliomaR01CA239721 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LASORELLA, ANNA · 2019 to 2023
$1.8M
The Ureb-1 ubiquitin ligase in neural stem cells and cancerR01CA131126 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LASORELLA, ANNA · 2008 to 2012
$1.6M
NCI NIH HHS R01 CA101644NCI NIH HHS R01 CA131126NCI NIH HHS R01 CA178546NCI NIH HHS R01 CA179044NCI NIH HHS R01 CA190891NCI NIH HHS R01 CA239721NCI NIH HHS U54 CA193313NINDS NIH HHS R01 NS061776
6 · The paper itself

Abstract

Activation of dual-specificity tyrosine-phosphorylation-regulated kinases 1A and 1B (DYRK1A and DYRK1B) requires prolyl hydroxylation by PHD1 prolyl hydroxylase. Prolyl hydroxylation of DYRK1 initiates a cascade of events leading to the release of molecular constraints on von Hippel-Lindau (VHL) ubiquitin ligase tumor suppressor function. However, the proline residue of DYRK1 targeted by hydroxylation and the role of prolyl hydroxylation in tyrosine autophosphorylation of DYRK1 are unknown. We found that a highly conserved proline in the CMGC insert of the DYRK1 kinase domain is hydroxylated by PHD1, and this event precedes tyrosine autophosphorylation. Mutation of the hydroxylation acceptor proline precludes tyrosine autophosphorylation and folding of DYRK1, resulting in a kinase unable to preserve VHL function and lacking glioma suppression activity. The consensus proline sequence is shared by most CMGC kinases, and prolyl hydroxylation is essential for catalytic activation. Thus, formation of prolyl-hydroxylated intermediates is a novel mechanism of kinase maturation and likely a general mechanism of regulation of CMGC kinases in eukaryotes.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SequenceAnimalsBinding SitesBrain NeoplasmsCell Line, TumorCrystallography, X-RayDyrk KinasesGene Expression Regulation, NeoplasticGliomaHEK293 CellsHeterograftsHumansHydroxylationHypoxia-Inducible Factor-Proline DioxygenasesIsoenzymesDyrk KinasesEGLN2 protein, humanHypoxia-Inducible Factor-Proline DioxygenasesIsoenzymesMitogen-Activated Protein Kinase 14ProlineProtein Serine-Threonine KinasesProtein-Tyrosine KinasesVHL protein, humanVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID32640193
PMCPMC7849370
OpenAlexW3041873161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.